• PW Medtech affiliate Sichuan Ruijian Medical posted 1H 2026 revenue of RMB 308.66 million, up 3.62%.
• Profit for the period rose 9.15% to RMB 76.74 million; profit attributable to shareholders increased 8.2% to RMB 78.91 million.
• Total assets were RMB 1.13 billion at June 30, 2026; total liabilities increased to RMB 154.65 million from RMB 99.01 million.
• Total equity fell to RMB 977 million from RMB 1.03 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PW Medtech Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12294390), on August 21, 2026, and is solely responsible for the information contained therein.